Consolidated Statement of Stockholders' Equity (Deficit) (Unaudited) - 6 months ended Jun. 30, 2017 - USD ($)	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	AOCI Attributable to Parent [Member]	Noncontrolling Interest [Member]	Total
Balance (in shares) at Dec. 31, 2016	92,975,970
Balance at Dec. 31, 2016	$ 62,179	$ 90,609,774	$ (91,915,426)	$ (81,694)	$ 554,969	$ (770,198)
Vendors and interest (in shares)	2,491,704
Vendors and interest	$ 1,734	502,259				504,263
Conversion of notes (in shares)	1,419,107
Conversion of notes	$ 952	529,048				$ 530,000
Exercise of warrants (in shares)	510,000					510,000
Exercise of warrants	$ 343	152,657				$ 153,000
Exercise of stock options (in shares)	2,501,937
Exercise of stock options	$ 1,677	(1,677)
Stock option compensation expense		515,959				515,959
Fair value of warrants and conversion feature issued as discount on convertible notes payable		225,000				225,000
Purchase of Clyra shares					(40,000)	(40,000)
Net loss			(4,340,703)		(237,167)	(4,577,870)
Foreign currency translation				(15,986)		(15,986)
Balance (in shares) at Jun. 30, 2017	99,898,718
Balance at Jun. 30, 2017	$ 66,885	$ 92,533,290	$ (96,256,129)	$ (97,680)	$ 277,802	$ (3,475,832)